Literature DB >> 10450836

Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension.

G Uçkaya1, M Ozata, A Sonmez, C Kinalp, T Eyileten, N Bingol, B Koc, F Kocabalkan, I C Ozdemir.   

Abstract

Previous studies demonstrated elevated plasma leptin and angiotensinogen (PRA) levels in essential hypertension. However, a few studies investigated the relationship between leptin and angiotensinogen levels in both lean and overweight/ obese hypertensives. The aim of the present study was therefore to examine the relationship between blood pressure, leptin and plasma renin activity in normotensives and in both lean and overweight/obese patients with essential hypertension. Two groups of subjects who were carefully matched for age, gender, waist:hip ratio and body mass index (BMI) were studied: 28 normotensives (NT) (age: 40.1+/-9.1 years old, BMI: 28.1+/-3.6 kg/m2, male/female: 18/10) and 33 newly diagnosed mild to moderate essential hypertensives (EHT) (age: 38.9+/-10 years old, BMI: 27.9+/-4.8 kg/m2, male/female: 22/11). No significant differences in age, gender, waist:hip ratio, fasting blood glucose and BMI were detected between EHT and NT groups. However, systolic and diastolic pressures, mean arterial blood pressures, plasma leptin levels and PRA were significantly higher in EHT group than in NT group (P = 0.001). Plasma leptin levels were strongly correlated with BMI in EHT (r=0.67, P = 0.001) and NT groups (r=0.44, P = 0.001). Plasma leptin levels were correlated with plasma PRA levels in both EHT and NT groups (r = 0.66 and r = 0.44; both P < 0.05, respectively). There was no correlation between leptin or PRA and systolic, diastolic pressures, or mean arterial blood pressures. Furthermore, the patients were divided as lean (n=16) and overweight/obese (n = 17) and compared with BMI-matched controls. In both subgroups, plasma leptin and PRA levels were also higher than those of controls. Our results showed that elevated plasma leptin and PRA are associated with hypertension in both lean and overweight/obese hypertensives. Moreover, plasma leptin was significantly correlated with plasma angiotensinogen levels. These findings suggest that adipose mass is an important determinant of blood pressure, although the mechanism is not clear.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450836     DOI: 10.1055/s-2007-978769

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  13 in total

Review 1.  New developments in mechanisms of obesity-induced hypertension: role of adipose tissue.

Authors:  A M Sharma; S Engeli; T Pischon
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 3.  Autonomic nervous system dysregulation in pediatric hypertension.

Authors:  Janusz Feber; Marcel Ruzicka; Pavel Geier; Mieczyslaw Litwin
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

Review 4.  Cardiometabolic syndrome: pathophysiology and treatment.

Authors:  Jonathan P Castro; Fadi A El-Atat; Samy I McFarlane; Ashish Aneja; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

5.  Association between adipocytokines and insulin resistance in Indian hypertensive patients.

Authors:  Sujata R Mahadik
Journal:  Indian Heart J       Date:  2012-03-26

6.  Human soluble leptin receptor concentration in healthy offspring of hypertensive parents.

Authors:  Dimitris P Papadopoulos; Thomas K Makris; Maria Poulakou; Urania G Papazachou; Antonios N Hatzizacharias; Despina N Perrea; Vassilios E Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

7.  Polymorphisms in the 3'UTR of the human leptin gene and their role in hypertension.

Authors:  Qulsum Akhter; Akbar Masood; Ruhi Ashraf; Sabia Majid; Sabah Rasool; Tanzeela Khan; Tabasum Rashid; A Syed Sameer; Bashir Ahmad Ganai
Journal:  Mol Med Rep       Date:  2012-01-04       Impact factor: 2.952

Review 8.  Leptin and hypertension in obesity.

Authors:  Paco E Bravo; Stephen Morse; David M Borne; Erwin A Aguilar; Efrain Reisin
Journal:  Vasc Health Risk Manag       Date:  2006

9.  Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).

Authors:  Henry R Black; Fernando Aguirre P; Melanie Wright; Thomas Alessi; Fabio Baschiera
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-07       Impact factor: 3.738

10.  Signatures of miR-181a on the Renal Transcriptome and Blood Pressure.

Authors:  Francine Z Marques; Simon Pr Romaine; Matthew Denniff; James Eales; John Dormer; Ingrid M Garrelds; Lukasz Wojnar; Katarzyna Musialik; Barbara Duda-Raszewska; Bartlomiej Kiszka; Magdalena Duda; Brian J Morris; Nilesh J Samani; Ah Jan Danser; Pawel Bogdanski; Ewa Zukowska-Szczechowska; Fadi J Charchar; Maciej Tomaszewski
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.